Yahoo Web Search

Search results

    • AstraZeneca drug regimen approved for endometrial cancer

      Becker’s Hospital Review· 6 days ago

      The FDA approved AstraZeneca's monotherapy for endometrial cancer, Imfinzi, after it was found in a study to decrease its risk of progression and death by 58% in patients who were diagnosed ...